Ueno Hideki, Klechevsky Eynav, Morita Rimpei, Aspord Caroline, Cao Tinghua, Matsui Toshimichi, Di Pucchio Tiziana, Connolly John, Fay Joseph W, Pascual Virginia, Palucka A Karolina, Banchereau Jacques
Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
Immunol Rev. 2007 Oct;219:118-42. doi: 10.1111/j.1600-065X.2007.00551.x.
The dendritic cell (DC) system of antigen-presenting cells controls immunity and tolerance. DCs initiate and regulate immune responses in a manner that depends on signals they receive from microbes and their cellular environment. They allow the immune system to make qualitatively distinct responses against different microbial infections. DCs are composed of subsets that express different microbial receptors and express different surface molecules and cytokines. Our studies lead us to propose that interstitial (dermal) DCs preferentially activate humoral immunity, whereas Langerhans cells preferentially induce cellular immunity. Alterations of the DC system result in diseases such as autoimmunity, allergy, and cancer. Conversely, DCs can be exploited for vaccination, and novel vaccines that directly target DCs in vivo are being designed.
抗原呈递细胞中的树突状细胞(DC)系统控制着免疫和耐受。DC以依赖于它们从微生物及其细胞环境接收的信号的方式启动和调节免疫反应。它们使免疫系统能够对不同的微生物感染做出性质上不同的反应。DC由表达不同微生物受体、不同表面分子和细胞因子的亚群组成。我们的研究使我们提出,间质(真皮)DC优先激活体液免疫,而朗格汉斯细胞优先诱导细胞免疫。DC系统的改变会导致自身免疫、过敏和癌症等疾病。相反,DC可用于疫苗接种,并且正在设计直接在体内靶向DC的新型疫苗。